Neuronal nicotinic receptors, important new players in brain function

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 3-10

  Clementi, Francesco ^a   Fornasari, Diego ^a   Gotti, Cecilia ^a  

^a CNR   (Italy)

Author keywords

Ageing; Dementia; Epilepsy; Neuronal nicotinic receptor; Nicotine; Nicotinic agent; Nicotinic receptor distribution; Schizophrenia; Tobacco addiction

Indexed keywords

CATION CHANNEL; NICOTINIC RECEPTOR; PROTEIN SUBUNIT; RECEPTOR SUBTYPE;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN FUNCTION; CHOLINERGIC TRANSMISSION; CONFERENCE PAPER; EVOLUTION; FRONTAL LOBE EPILEPSY; HUMAN; IMMUNOHISTOCHEMISTRY; MUSCLE CELL; NERVE CELL; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STRUCTURE; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SMOKING HABIT;

BRAIN; BRAIN DISEASES; CHOLINERGIC AGENTS; HUMANS; NEURONS; RECEPTORS, NICOTINIC; TISSUE DISTRIBUTION;

EID: 0034732138     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00066-2     Document Type: Conference Paper

References (78)

1. Albuquerque E.X., Pereira E.F., Braga M.F., Alkondon M. Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors. J. Physiol. Paris. 92:1998;309-316.
2. Asher P., Large W.A., Rang H.P. Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells. J. Physiol. 155:1979;372-384.
3. Badio B., Daly J.W. Epibatidine, a potent analgetic and nicotinic agonist. Mol. Pharmacol. 45:1994;563-569.
4. Baron J.A Cigarette smoking and Parkinson's disease. Neurology. 36:1996;1490-1496.
5. Battaglioli E., Gotti C., Terzano S., Flora A., Clementi F., Fornasari D. Expression and transcriptional regulation of the human alfa 3 neuronal nicotinic receptor subunit in T lymphocyte cell lines. J. Neurochem. 71:1998;1261-1270.
6. Bencherif M., Lovette M.E., Fowler K.W., Arrington S., Reeves L., Caldwell W.S., Lippiello P.M. RJR-2403: a nicotinic agonist with CNS selectivity I: in vitro characterization. J. Pharmacol. Exp. Ther. 279:1996;1413-1421.
7. Bertrand D., Changeux J.P. Nicotinic receptor; an allosteric protein specialized for intracellular communication. Sem. Neurosci. 7:1995;75-90.
8. Briggs C.A., Anderson D.J., Brioni J.D., Buccafusco J.J., Buckley M.J., Campbell J.E., Decker M.W., Donnelly-Roberts D., Elliott R.L., Gopalakrishnan M., Holladay M.W., Hui Y.H., Jackson W.J., Kim D.J., Marsh K.C., O'Neill A., Prendergast M.A., Ryther K.B., Sullivan J.P., Arneric S.P. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol. Biochem. Behav. 57:1997;231-241.
9. Changeux J.P., Edelstein S.J. Allosteric receptors after 30 years. Neuron. 21:1998;959-980.
10. Chini B., Clementi F., Hukovic N., Sher E. Neuronal-type α-bungarotoxin receptors and the α5-nicotinic receptor subunit gene are expressed in neuronal and non-neuronal human cell lines. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1572-1576.
11. Colquhoun L.M., Patrick J.W. Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv. Pharmacol. 39:1997;191-220.
12. Corriveau R.A., Berg D.K. Coexpression of multiple acetylcholine receptor genes in neurons: quantification of transcripts during development. J. Neurosci. 13:1993;2662-2671.
13. Court J.A., Lloyd S., Johnson M., Griffiths M., Birdsall N.J., Pigott M.A., Oakley A.E., Ince P.G., Pery E.K., Perry R.H. Nicotinic and muscarinic choluinergic receptoer binding in the human hippocampal formation during development and aging. Dev. Brain Res. 101:1997;93-105.
14. Convernton P.J., Kojima H., Sivilotti L.G., Gibb A.J., Colquhoun D. Comparison of neuronal nicotinic receptors in rat sympathetic neurones with subunit pairs expressed in Xenopus oocytes. J. Physiol. (Lond.). 481:1994;27-34.
15. Fournasari D., Battaglioli E., Terzano S., Clementi F. Transcriptional regulation of neuronal nicotinic receptor subunit genes. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. 1999;25-42 Wiley-Liss, NewYork.
16. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U.S.A. 94:1997;587-592.
17. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., Lindstrom J. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:1995;774-782.
18. 2+ modulation of human neuronal α3 nicotinic receptors. J. Pharmacol. Exp. Ther. 286:1998;311-320.
19. Goldner F.M., Dineley K.T., Patrick J.W. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and ventral tegmental area. Neuroreport. 8:1997;2739-2742.
20. Gordon J., Gurley O., Tran A., Machulskis A., Zongrone J., Luhowskj S., Ryan T., Mack R., Loch J. III, Balestra M., Decory T., Sampognaro A., Wright N., Verhoest P., Macor J., Kover A., Wu E., Griffith R., Mullen G., Murray R., Blosser J. AR-R17779: the first high affinity, subtype-selective full agonist at the rodent α7 nicotinic acetylcholine receptor. Soc. Neurosci. Abstr. 331.9:1998.
21. Gotti C., Balestra B., Moretti M., Rovati G.E., Maggi L., Rossoni G., Berti F., Villa L., Pallavicini M., Clementi F. 4-oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors. Br. J. Pharmacol. 124:1998;1197-1206.
22. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog. Neurobiol. 53:1997;199-237.
23. Gotti C., Moretti M., Maggi R., Longhi R., Hanke W., Klinke N., Clementi F. α7 and α8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties. Eur. J. Neurosci. 9:1997;1201-1211.
24. Grando S.A., Horton R.M., Pereira E.F., Diethlem-Okita B.M., George P.M., Albuquerque E.X., Conti Fine B.M. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J. Invest. Dermatol. 105:1995;774-781.
25. Guo J.Z., Tredway T.L., Chiappinelli V.A. Glutamate and GABA release are enhanced by different subtypes of presynaptic nicotinic receptors in the lateral geniculate nucleus. J. Neurosci. 18:1998;1963-1969.
26. Hellström-Lindahl E., Mousavi M., Zhang X., Ravid R., Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Mol. Brain Res. 66:1999;94-103.
27. Holladay M.W., Dart M.J., Lynch J.K. Neuronal nicotinic acetylcholine receptors as targets for drug discovery. J. Med. Chem. 40:1997;4169-4194.
28. Jones S., Sudweeks S., Yakel J.L. Nicotinic receptors in the brain: correlating physiology with function. Trend Neurol. Sci. 22:1999;555-561.
29. Kem W.R. Alzheimer's drug design based upon an invertebrate toxin (anabaseine) which is a potent nicotinic receptor agonist. Invertbr. Neurosci. 3:1997;251-259.
30. Kristufek D., Stocker E., Boehm S., Huck S. Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles. J. Physiol. (Lond.). 516:1999;739-756.
31. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. J. Neurosci. 17:1997;9035-9047.
32. Langley J.H. On the reaction of cells and of nerve endings to certain poisons chiefly as regards the reaction of striated muscle to nicotine and curare. J. Physiol. 33:1905;374-413.
33. Langley J.H. Croonian lecture. On nerve endings and on special excitable substances in cells. Proc. Royal Soc. Series B. 78:1906;170-194.
34. Le Novère N., Changeux J.P. Molecular evolution of the nicotinic acetylcholine receptor: an example of multigene family in excitable cells. J. Mol. Evol. 40:1995;155-172.
35. Le Novère N., Zoli M., Changeux J.P. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8:1996;2428-2439.
36. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22:1996;431-445.
37. Lindstrom J. The structure of nAChRs; Clementi F., Fornasari D., Gotti C. Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology. Vol. 144:2000;Springer-Verlag, Berlin. in press.
38. Lloyd G.K., Menzaghi F., Bontempi B., Suto C., Siegel R., Akong M., Stauderman K., Velicelebi G., Johnson E., Harpold M.M., Rao T.S., Sacaan A.I., Chavez-Noriega L.E., Washburn M.S., Vernier J.M., Cosford N.D., McDonald L.A. The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sci. 62:1998;1601-1606.
39. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 8(287):1998;648-657.
40. Luetje C.W., Patrick J. Both α- and β-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
41. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57:1995;521-546.
42. McIntosh J.M. Toxin antagonists of the neuronal nAChR. Clementi F., Fornasari D., Gotti C. Neuronal Nicotinic Receptors, Handbook Of Experimental Pharmacology. Vol. 144:2000;Springer-Verlag, Berlin. in press.
43. Maggi L., Palma E., Eusebi F., Moretti M., Balestra B., Clementi F., Gotti C. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor. Br. J. Pharmacol. 126:1999;285-295.
44. Martin-Ruiz C.M., Court J.A., Molnar E., Lee M., Gotti C., Mamalaki A., Tsouloufis T., Tzartos S., Ballard C., Perry R.H., Perry E.K. α4 but not α3 and α7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J. Neurochem. 73:1999;1635-1640.
45. Marubio L., Changeux J.P. Knock-out animals as models for studying NAChR function. Clementi F., Fornasari D., Gotti C. Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology. Vol. 144:2000;Springer-Verlag, Berlin. in press.
46. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novère N., de Kerchove d'Exaerde A., Huchet M., Damaj M.I., Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature. 398:1999;805-810.
47. Mesulam M.M., Geula C. Nucleus basalis and cortical cholinergic innervation in the human brain: observation based on the distribution of AChE and ChAT. J. Comp. Neurol. 275:1988;216-240.
48. Mesulam M.M., Geula C., Botwell M.A., Hersch I. Human reticular formsation; cholinergic neurons of the peduncolopontine and laterodorsal tegmental nuclei and some cytochemical comparison to forebrain cholinergic neurons. J. Comp. Neurol. 281:1989;611-633.
49. Nordberg A., Alafuzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31:1992;103-111.
50. Nordberg A., Adem A., Bachtt G., Vitanem M., Winblad B. Alteration in lymphocyte receptor densities in dementia of Alzheimer type: a possible diagnostic marker. Fowler C.et al. Biological markers in Dementia of Alzheimer type. 1990;149-159 Smith-Gordon, London.
51. Nordberg A., Hartvig P., Lilja A., Viitanen M., Amberla K., Lundqvist H., Andersson Y., Ulin J., Winblad B., Langström B. Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography. J. Neural. Transm. Parkinson's Dis. Dementia Sect. 2:1990;215-224.
52. Palma E., Bertrand S., Binzoni T., Bertrand D. Neuronal nicotinic α7 receptor expressed in Xenopus oocytes putative binding sites for methyllycaconitine. J. Physiol. (Lond.). 491:1996;151-161.
53. Papke R.L. The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Prog. Neurobiol. 41:1993;509-531.
54. Papke R.L., Thinschmidt J.S., Moulton B.A., Meyer E.M., Poirier A. Activation and inhibition of rat neuronal nicotinic receptors by ABT-418. Br. J. Pharmacol. 120:1997;429-438.
55. Parker M.J., Beck A, Luetje C.W. Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity. Mol. Pharmacol. 54:1998;1132-1139.
56. Paton W.D.M., Zaimis E.J. Paralysis of autonomic ganglia by methonium salts. Br. J. Pharmacol. 6:1951;155-168.
57. Picciotto M.R., Zoli M., Léna C., Bessis A., Lallemand Y., Le Novére N., Vincent P., Merlo Pich E., Brûlet P., Changeux J.P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature. 374:1995;65-67.
58. Poth K., Nutter T.J., Cuevas J., Parker M.J., Adams D.J., Luetje C.W. Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia. J. Neurosci. 17:1997;586-596.
59. Pough P.C., Berg D.K. Neuronal acetylcholine receptorsthat bind α-bungarotoxin mediate neurite retractionin a calcium-dependent manner. J. Neurosci. 14:1994;889-895.
60. Radcliffe K.A., Fisher J.L., Gray R., Dani J.A. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons. Ann. N.Y. Acad. Sci. 868:1999;591-610.
61. Rubboli F., Court J.A., Sala C., Morris C., Chini B., Perry E., Clementi F. Distribution of nicotinic receptors in the human hippocampus and thalamus. Eur. J. Neurosci. 6:1994;1596-1604.
62. Sala C., Kimura I., Santoro G., Kuimura M., Fumagalli G. Expression of two neuronal nicotinic receptor subunits in innervated and denervated adult rat muscle. Neurosci. Lett. 214:1996;1-4.
63. Sargent P.B. The diversity of neuronal nicotinic acetylcholine receptors. Ann. Rev. Neurosci. 16:1993;403-443.
64. Sivilotti L.G., McNeil D.K., Lewis T.M., Nassar M.A., Schoepfer R., Colquhoun D. Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J. Physiol. (Lond.). 500:1997;123-138.
65. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., Nakken K.O., Propping P., Bertrand D. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Hum. Mol. Genet. 6:1997;943-947.
66. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., Scheffer I.E., Berkovic S.F. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11:1995;201-203.
67. Unwin N. Nicotinic acetylcholine receptor at 9 Å resolution. J. Mol. Biol. 229:1993;1101-1124.
68. Unwin N. Projection structure of the nicotinic acetylcholine receptor: distinct conformations of the alpha subunits. J. Mol. Biol. 257:1996;586-596.
69. Vailati S., Hanke W., Bejan A., Barabino B., Longhi R., Balestra B., Moretti M., Clementi F., Gotti C. Functional α6-containing nicotinic receptors are present in chick retina. Mol. Pharmacol. 56:1999;11-19.
70. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. Distribution of α2, α3, α4, and β2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J. Comp. Neurol. 284:1989;314-335.
71. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., Lindstrom J. Assembly of human neuronal nicotinic receptor α5 subunits with α3, β2, and β4 subunits. J. Biol. Chem. 271:1996;17656-17665.
72. Wess J., Buhl T., Lambrecht G., Mutschler E. Cholinergic receptors. Hansch C., Sammes P.G., Taylor J.B. Comprehensive Medicinal Chemistry: The Rational Design, Mechanistic Study and Therapeutic Application of Chemical Compounds. Vol. 3:1990;423-491 Pergamon, Oxford.
73. Wevers A., Monteggia L., Nowacki S., Bloch W., Schütz U., Lindstrom J., Pereira E.F.R., Eisenberg H., Giacobini E., de Vos R.A.I., Jansen Steur E.N.H., Maelicke A., Albuquerque E.X., Schrüder H. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein. Eur. J. Neurosci. 11:1999;2551-2565.
74. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
75. Wonnacott S., Albuquerque E.X., Bertrand D. Methyllycaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses. Conn P.M. Methods in Neurosciences: Receptors: Molecular Biology, Receptor Subclasses, Localization and Ligand Binding. Vol. 12:1993;263-275 Academic Press.
76. Xu W., Orr-Urtreger A., Nigro F., Gelber S., Sutcliffe C.B., Armstrong D., Patrick J., Role L., Beaudet A.L., De Biasi M. Multiorgan autonomic dysfunction in mice lacking the B2 and the B4 subunits of neuronal nicotinic acetylcholine receptors. J. Neurosci. 19:1999;9298-9305.
77. Zaimis E. Neuromuscular function. Handbook of Experimental Pharmacology. Vol. 42:1976;Springer-Verlag, Berlin.
78. Zoli M. NAChR in development and ageing. Clementi F., Fornasari D., Gotti C. Neuronal Nicotinic Receptors, Handbook of Experimental Pharmacology. Vol. 144:2000;Springer-Verlag, Berlin. in press.